New Formulation of Rotarix Removes the Need for Reconstitution
The new liquid formulation of Rotarix does not require reconstitution or dilution before use.
The new liquid formulation of Rotarix does not require reconstitution or dilution before use.
Bebtelovimab is currently authorized for emergency use for the treatment of mild to moderate COVID-19 in adults and pediatric patients.
The approval was supported by data from a phase 2 trial that included 70 patients aged 12 to less than 18 years with chronic HBV infection.
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
Prompt initiation of systemic antiviral therapy in addition to topical trifluridine should be considered in patients with ocular manifestations of monkeypox.
Molnupiravir is a nucleoside analogue that inhibits SARS-CoV-2 replication by viral mutagenesis.
The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks.
A woman in her mid-40s presents to the emergency department with a history of nausea and pleuritic-like chest pain. Can you make the diagnosis?
The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
Recognize the signs and symptoms of red eye that differentiate benign from vision-threatening ophthalmologic illnesses.